ELI LILLY & CO (LLY)
Clinical trial NCT06897475 updates: 1. completion date: 2027-01-01 → 2027-06-01 2. primary completion date: 2026-12-01 → 2027-05-01 3. enrollment: 240 → 200 participants
Clinical trial NCT06897475 updates: 1. completion date: 2027-01-01 → 2027-06-01 2. primary completion date: 2026-12-01 → 2027-05-01 3. enrollment: 240 → 200 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical